cromakalim has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatano, Y; Iranami, H; Iwahashi, S; Kakutani, T; Kinoshita, H; Mizumoto, K | 1 |
1 other study(ies) available for cromakalim and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
Article | Year |
---|---|
The role of endothelium-derived nitric oxide in relaxations to levcromakalim in the rat aorta.
Topics: Animals; Aorta, Thoracic; ATP-Binding Cassette Transporters; Benzoates; Cromakalim; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Hydrazines; Imidazoles; KATP Channels; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Inbred WKY; Vasodilator Agents | 1999 |